ALFA Finder| Value | ₹1,554 Cr |
|---|
BSE filing, NSE: ONESOURCE. Summary written from the filing by ALFA Finder's alert engine.
OneSource Specialty Pharma Ltd: key numbers
- Share price
- ₹1,599.80
- Market cap
- ₹18,346 Cr
- Revenue (annual)
- ₹1,422 Cr
- Net profit (annual)
- ₹-73.80 Cr
- P/E (TTM)
- -11317.2×Sector 43.0×
- Promoter holding
- 30.47%-0.01% QoQ
- FII holding
- 19.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from OneSource Specialty Pharma Ltd
All →OneSource Specialty Pharma Business Update
OneSource received a USFDA EIR with VAI classification for its Bengaluru SPD facility. This marks completion of the June 2026 inspection with no monetary penalty.
OneSource Specialty Pharma Earnings Call Transcript: Key Takeaways
Onesource Specialty Pharma delivered its third consecutive growth quarter, driven by new sterile cartridge capacity.
OneSource Specialty Pharma Results Update
OneSource announced Q2FY27 results with revenue up 37% YoY and EBITDA up 53% YoY. An investor presentation was filed alongside the press release.
OneSource Specialty Pharma Employee Stock Options
OneSource Specialty Pharma allotted 360 equity shares under its ESOP 2021 scheme to an eligible employee. Paid-up share capital increased to 11,46,74,151 shares of ₹1 each.
OneSource Specialty Pharma Management Change
Dr. Claudio Albrecht's designation changed from Independent Director to Non-Executive Non-Independent Director, effective 27 Oct 2026. The change is subject to shareholder approval at the upcoming meeting.
OneSource Specialty Pharma Q2 FY27 Results: Net Profit ₹57.5 Cr, Up 447.6% YoY
OneSource Specialty Pharma Ltd reported revenue from operations of ₹516.2 Cr (+37.4% YoY) and net profit of ₹57.5 Cr (+447.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹57.5 Cr · +447.6% YoY
Other credit rating announcements
All →Vikran Engineering Credit Rating
India Ratings revised Vikran Engineering's outlook to Negative and assigned IND BBB+ to proposed NCDs. The revision reflects equity infusion needs and high working capital utilisation.
Manorama Industries Credit Rating
Manorama Industries Ltd disclosed that India Ratings upgraded its bank loan facilities to IND A+/Positive/IND A1+. The rated facilities total INR 4,967.70 million.
HBL Engineering Credit Rating
HBL Engineering's CARE rating was revised, with long-term rating reaffirmed at CARE AA-; Stable. Long-term/short-term facilities were assigned a stable outlook with short-term CARE A1+ reaffirmed.
Metal Coatings (India) Credit Rating
Acuité Ratings reaffirmed Metal Coatings' long-term ACUITE BBB and short-term ACUITE A3+ ratings on bank loans. The rated facilities total Rs 15 Crore, with a stable outlook.
Shyam Metalics and Energy Credit Rating
CRISIL reaffirmed Shyam Metalics' long-term AA+ and short-term A1+ ratings with Stable outlook, plus its Rs. 50 Crore commercial paper rating. The action is dated 2026-11-04 and verified.
Mangalam Global Enterprise Credit Rating
Acuite assigned BBB+ and provisional A- ratings to the company's NCDs, totalling Rs 135 crore. Both ratings carry a Stable outlook.